Related Experiment Videos

Thrombosis and anticoagulation

J Hirsh1, J I Weitz

  • 1Hamilton Civic Hospitals Research Centre, Ontario, Canada.

Seminars in Hematology
|December 14, 1999
PubMed

Insights

Recent advances in thrombosis research have yielded novel antithrombotic agents targeting blood coagulation and platelet activation. Future therapies may focus on modulating vessel wall function to prevent and treat thrombosis.

Area of Science:

  • Biomedical Sciences
  • Clinical Trials Methodology
  • Thrombosis Research

Background:

  • Thrombosis research has significantly advanced over the past 50 years.
  • Progress is driven by improvements in biomedical sciences and clinical trials.
  • Understanding thrombogenesis mechanisms is key.

Observation:

  • New antithrombotic agents targeting coagulation and platelet activation have been discovered.
  • Low-molecular-weight heparins (LMWH), glycoprotein (GP) IIb/IIIa antagonists, and adenosine diphosphate (ADP) receptor inhibitors are clinically used.
  • The vessel wall plays a dual role in promoting and protecting against thrombosis.

Findings:

  • Numerous antithrombotic compounds are in development.
  • Established therapies include LMWH, GP IIb/IIIa antagonists, and ADP receptor inhibitors.
  • Emerging therapies aim to modulate vessel wall function.

Implications:

  • These developments offer improved prevention and treatment strategies for thrombosis.
  • Future research focuses on vessel wall-targeted therapies.
  • Continued progress in thrombosis research promises enhanced patient outcomes.

Related Concept Videos